How to Engage Your Members of Congress
- Featured in:
- The Neuroscientist’s Guide to Advocacy
Jul 07, 2017
July 25, 2017
1:00 PM - 12:00 PM EDT
Neuroscientists at all career stages have meaningful perspectives to share with policymakers about why supporting the scientific enterprise is so important for the field and society. In this webcast, you will learn ways that you can persuasively advocate for science, and hear how recent Congressional actions may impact funding for biomedical research issues and your work.
Access to the full article is available to SfN members.
Neuronline is a benefit of SfN membership. Renew your membership now to make sure you don’t lose access.
Speakers
Bill Martin, PhD
Bill Martin leads the neuroscience therapeutic area of Janssen Research & Development, LLC in discovering and developing important new therapies for people living with brain disorders. Prior to joining BlackThorn, Martin worked at Theravance Biopharma, where his responsibilities ranged from drug discovery and development, to research portfolio planning and business development. He is the chair of SfN’s Government and Public Affairs Committee. Martin graduated from Swarthmore College and earned his PhD from Brown University. He conducted postdoctoral research at the Keck Center for Integrative Neuroscience at the University of California, San Francisco.
Brenda Bloodgood, PhD
Brenda Bloodgood is an assistant professor of neurobiology in the Division of Biological Sciences at UC San Diego. Bloodgood’s main research interests lie in how neuronal computations change in response to environmental interactions. She received her BS in animal physiology and neuroscience from UC San Diego and her PhD in neurobiology from Harvard Medical School. She completed her postdoctoral training at Harvard Medical School.
Lyle Dennis
Lyle B. Dennis is a partner in Cavarocchi-Ruscio-Dennis Associates, a government relations firm in Washington, DC. He serves as a member of the steering committee of the Ad Hoc Group for Medical Research, the leading advocacy group for NIH. Dennis frequently lectures about public policy issues at universities and in front of corporate and not-for-profit organizations.
0 of 5 articles left
Login
or
Become a Member
to unlock content